Skip to main content
. 2018 Jul 25;2018(7):CD012171. doi: 10.1002/14651858.CD012171.pub2

Singer 2000.

Methods Double‐blind, 2‐arm, parallel‐group, randomised controlled trial, with active comparator (no placebo) and 1 application for 15 minutes
Participants Setting: single centre, university hospital emergency department, USA
Sample size:
  • Number randomised: 50 participants, 50 ears

  • Number completed: 50 participants, 50 ears


Participant baseline characteristics:
  • Age: 1 to 81 years old (mean age 40 years)

  • Gender: 35% female


Inclusion criteria: 1 year or older, presenting to emergency department with a condition requiring visualisation of the tympanic membrane and wax present
Exclusion criteria: tympanic membrane perforation, infection, uncooperative, allergies to ingredients
Interventions Intervention group 1 (n = 27 participants; 27 ears): docusate sodium (Colace), 1 mL, once, wait 15 minutes
Intervention group 2 (n = 23 participants; 23 ears): triethanolamine polypeptide (Cerumenex), 1 mL, once, wait 15 minutes
Use of additional interventions: syringing if required after treatment with drops was measured and assessed
Outcomes Primary outcomes:
  • Proportion of patients with complete clearance of wax


Secondary outcomes:
  • Adverse effects


Other outcomes reported by the study:
  • Ease of mechanical removal


Timing of measurements:
  • After 15 minutes of ear drops, before syringing if required

  • After syringing if required

Funding sources No information provided
Declarations of interest No information provided
Notes Participants lost to follow‐up: none
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Quote: "assignments were generated by a computerised randomisation programme"
Allocation concealment (selection bias) Low risk Quote: "for each patient, the next in a series of opaque, consecutively numbered 2‐mL syringes were used. Syringes were prepared by hospital pharmacy personnel and not connected to the ED or enrolment process"
Blinding of participants and personnel (performance bias) 
 All outcomes Low risk Quote: "for each patient, the next in a series of opaque, consecutively numbered 2‐mL syringes were used. Syringes were prepared by hospital pharmacy personnel and not connected to the ED or enrolment process"
Blinding of outcome assessment (detection bias) 
 All outcomes High risk Comment: observer bias may have occurred as the solutions were different colours
Incomplete outcome data (attrition bias) 
 All outcomes Low risk Comment: no missing data; no withdrawals mentioned
Selective reporting (reporting bias) Low risk Comment: all outcomes proposed in the methods were reported in the results
Other bias Low risk Comment: no further sources of bias identified